Sulfamide-based inhibitors for carboxypeptidase A. Novel type transition state analogue inhibitors for zinc proteases. 2002

Jung Dae Park, and Dong H Kim, and Seung-Jun Kim, and Joo-Rang Woo, and Seong Eon Ryu
Center for Integrated Molecular Systems, Division of Molecular and Life Sciences, Pohang University of Science and Technology, San 31 Hyoja-dong, Namku, Pohang 790-784 Korea.

N-Sulfamoylphenylalanine and its derivatives having varied alkyl groups on the terminal amino group were designed rationally as transition state analogue inhibitors for carboxypeptidase A (CPA) and synthesized. In CPA inhibitory assays the parent compound having the (S)-configuration, i.e., (S)-1a, showed potent inhibitory activity with the K(i) value of 0.64 microM. Its enantiomer was shown to be much less potent (K(i) = 470 microM). Introduction of an alkyl group such as methyl or isopropyl group on the terminal amino group of (S)-1a lowered the inhibitory potency drastically. Introduction of a methyl group on the internal amino group of (S)-1a also caused a drastic reduction of the inhibitory activity. The structure of the CPA x(S)-1a complex determined by single-crystal X-ray diffraction reveals that the sulfamoyl moiety interacts with the zinc ion and functional groups at the active site of CPA, which is reminiscent of the postulated stabilization mode of a tetrahedral transition state in the CPA-catalyzed hydrolysis of a peptide substrate. On the basis of the design rationale and the binding mode of (S)-1a to CPA shown by X-ray crystallographic analysis, the present inhibitors are inferred to be a novel type of transition state analogue inhibitor for CPA.

UI MeSH Term Description Entries
D008958 Models, Molecular Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures. Molecular Models,Model, Molecular,Molecular Model
D010649 Phenylalanine An essential aromatic amino acid that is a precursor of MELANIN; DOPAMINE; noradrenalin (NOREPINEPHRINE), and THYROXINE. Endorphenyl,L-Phenylalanine,Phenylalanine, L-Isomer,L-Isomer Phenylalanine,Phenylalanine, L Isomer
D002268 Carboxypeptidases Enzymes that act at a free C-terminus of a polypeptide to liberate a single amino acid residue. Carboxypeptidase
D004791 Enzyme Inhibitors Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. Enzyme Inhibitor,Inhibitor, Enzyme,Inhibitors, Enzyme
D013237 Stereoisomerism The phenomenon whereby compounds whose molecules have the same number and kind of atoms and the same atomic arrangement, but differ in their spatial relationships. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 5th ed) Molecular Stereochemistry,Stereoisomers,Stereochemistry, Molecular,Stereoisomer
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D013449 Sulfonamides A group of compounds that contain the structure SO2NH2. Sulfonamide,Sulfonamide Mixture,Sulfonamide Mixtures,Mixture, Sulfonamide,Mixtures, Sulfonamide
D015032 Zinc A metallic element of atomic number 30 and atomic weight 65.38. It is a necessary trace element in the diet, forming an essential part of many enzymes, and playing an important role in protein synthesis and in cell division. Zinc deficiency is associated with ANEMIA, short stature, HYPOGONADISM, impaired WOUND HEALING, and geophagia. It is known by the symbol Zn.
D015394 Molecular Structure The location of the atoms, groups or ions relative to one another in a molecule, as well as the number, type and location of covalent bonds. Structure, Molecular,Molecular Structures,Structures, Molecular
D043422 Carboxypeptidases A Carboxypeptidases that are primarily found the DIGESTIVE SYSTEM that catalyze the release of C-terminal amino acids. Carboxypeptidases A have little or no activity for hydrolysis of C-terminal ASPARTIC ACID; GLUTAMIC ACID; ARGININE; LYSINE; or PROLINE. This enzyme requires ZINC as a cofactor and was formerly listed as EC 3.4.2.1 and EC 3.4.12.2. Carboxypeptidase A,Carboxypeptidase A1,Carboxypeptidase A2,Carboxypeptidase A5,PCPA1 Enzyme,PCPA2 Enzyme,Procarboxypeptidase A,Procarboxypeptidase A1,Procarboxypeptidase A2

Related Publications

Jung Dae Park, and Dong H Kim, and Seung-Jun Kim, and Joo-Rang Woo, and Seong Eon Ryu
July 1989, Biochemistry,
Jung Dae Park, and Dong H Kim, and Seung-Jun Kim, and Joo-Rang Woo, and Seong Eon Ryu
December 1985, Journal of medicinal chemistry,
Jung Dae Park, and Dong H Kim, and Seung-Jun Kim, and Joo-Rang Woo, and Seong Eon Ryu
August 2002, Organic letters,
Jung Dae Park, and Dong H Kim, and Seung-Jun Kim, and Joo-Rang Woo, and Seong Eon Ryu
October 1985, Proceedings of the National Academy of Sciences of the United States of America,
Jung Dae Park, and Dong H Kim, and Seung-Jun Kim, and Joo-Rang Woo, and Seong Eon Ryu
January 2003, Biochemistry,
Jung Dae Park, and Dong H Kim, and Seung-Jun Kim, and Joo-Rang Woo, and Seong Eon Ryu
February 2008, Journal of medicinal chemistry,
Jung Dae Park, and Dong H Kim, and Seung-Jun Kim, and Joo-Rang Woo, and Seong Eon Ryu
November 1999, Bioorganic & medicinal chemistry,
Jung Dae Park, and Dong H Kim, and Seung-Jun Kim, and Joo-Rang Woo, and Seong Eon Ryu
September 1983, Biochemistry,
Jung Dae Park, and Dong H Kim, and Seung-Jun Kim, and Joo-Rang Woo, and Seong Eon Ryu
August 1982, Biochemistry,
Jung Dae Park, and Dong H Kim, and Seung-Jun Kim, and Joo-Rang Woo, and Seong Eon Ryu
December 2003, Organic letters,
Copied contents to your clipboard!